Drug Discovery market research reports by China Research and Intelligence Co., Ltd.

Investigation Report on China's Infliximab Market 2022-2031

Jul 25, 2022  |  Published by: China Research and Intelligence Co., Ltd.  |  USD 3,200

Investigation Report on China's Infliximab Market 2022-2031 Infliximab is a human-mouse chimeric IgG1 monoclonal antibody targeting tumor necrosis factor (TNF-α) (composed of human IgG1 constant region and mouse variable region). It is used to treat a variety of autoimmune diseases, including ... Read More